A "Millió no vizsgálat" és kritikája

Translated title of the contribution: Million Women Study and its criticism

János Dancsó, Imre Cseh, Beáta Kanizsai, György Végh, V. Fülöp

Research output: Contribution to journalArticle

Abstract

In the Million Women Study, published in August 2003 participated nearly one million posstmenopausal women. The authors found unusually high breast cancer risk among the estrogen-progesterone hormone treated patients, and small, but significant increases in other hormone treated groups, including tibolone. Following publication of the Million Women Study, the Committee of Safety of Medicines wrote to all doctors in UK, advising them of breast cancer risk associated with HRT. As a results of the warnings, many women have been wrongly advised to stop, or not even start HRT, with subsequent deterioration in their general health and weell-being. It coused concern among health professionals and women about the use of menopausal hormon treatment. We give an extensive response to the article and its critics, highlighting flaws in the design of the study, which now render unsound any firm conclusions drawn from it. There are concerns that the study over-estimated the risk of breast cancer associated with a short exposure to menopausal hormone therapy.

Original languageHungarian
Pages (from-to)123-130
Number of pages8
JournalMagyar Noorvosok Lapja
Volume67
Issue number3
Publication statusPublished - 2004

Fingerprint

tibolone
Hormones
Breast Neoplasms
Women's Health
Progesterone
Publications
Estrogens
Safety
Health
Therapeutics

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Dancsó, J., Cseh, I., Kanizsai, B., Végh, G., & Fülöp, V. (2004). A "Millió no vizsgálat" és kritikája. Magyar Noorvosok Lapja, 67(3), 123-130.

A "Millió no vizsgálat" és kritikája. / Dancsó, János; Cseh, Imre; Kanizsai, Beáta; Végh, György; Fülöp, V.

In: Magyar Noorvosok Lapja, Vol. 67, No. 3, 2004, p. 123-130.

Research output: Contribution to journalArticle

Dancsó, J, Cseh, I, Kanizsai, B, Végh, G & Fülöp, V 2004, 'A "Millió no vizsgálat" és kritikája', Magyar Noorvosok Lapja, vol. 67, no. 3, pp. 123-130.
Dancsó J, Cseh I, Kanizsai B, Végh G, Fülöp V. A "Millió no vizsgálat" és kritikája. Magyar Noorvosok Lapja. 2004;67(3):123-130.
Dancsó, János ; Cseh, Imre ; Kanizsai, Beáta ; Végh, György ; Fülöp, V. / A "Millió no vizsgálat" és kritikája. In: Magyar Noorvosok Lapja. 2004 ; Vol. 67, No. 3. pp. 123-130.
@article{549c699527694d3fa910c60ec53dbbca,
title = "A {"}Milli{\'o} no vizsg{\'a}lat{"} {\'e}s kritik{\'a}ja",
abstract = "In the Million Women Study, published in August 2003 participated nearly one million posstmenopausal women. The authors found unusually high breast cancer risk among the estrogen-progesterone hormone treated patients, and small, but significant increases in other hormone treated groups, including tibolone. Following publication of the Million Women Study, the Committee of Safety of Medicines wrote to all doctors in UK, advising them of breast cancer risk associated with HRT. As a results of the warnings, many women have been wrongly advised to stop, or not even start HRT, with subsequent deterioration in their general health and weell-being. It coused concern among health professionals and women about the use of menopausal hormon treatment. We give an extensive response to the article and its critics, highlighting flaws in the design of the study, which now render unsound any firm conclusions drawn from it. There are concerns that the study over-estimated the risk of breast cancer associated with a short exposure to menopausal hormone therapy.",
keywords = "Beast cancer risk, Estrogen-progesterone therapy, Menopausa",
author = "J{\'a}nos Dancs{\'o} and Imre Cseh and Be{\'a}ta Kanizsai and Gy{\"o}rgy V{\'e}gh and V. F{\"u}l{\"o}p",
year = "2004",
language = "Hungarian",
volume = "67",
pages = "123--130",
journal = "Magyar Noorvosok Lapja",
issn = "0025-021X",
publisher = "Magyar Noovos Tarsasag",
number = "3",

}

TY - JOUR

T1 - A "Millió no vizsgálat" és kritikája

AU - Dancsó, János

AU - Cseh, Imre

AU - Kanizsai, Beáta

AU - Végh, György

AU - Fülöp, V.

PY - 2004

Y1 - 2004

N2 - In the Million Women Study, published in August 2003 participated nearly one million posstmenopausal women. The authors found unusually high breast cancer risk among the estrogen-progesterone hormone treated patients, and small, but significant increases in other hormone treated groups, including tibolone. Following publication of the Million Women Study, the Committee of Safety of Medicines wrote to all doctors in UK, advising them of breast cancer risk associated with HRT. As a results of the warnings, many women have been wrongly advised to stop, or not even start HRT, with subsequent deterioration in their general health and weell-being. It coused concern among health professionals and women about the use of menopausal hormon treatment. We give an extensive response to the article and its critics, highlighting flaws in the design of the study, which now render unsound any firm conclusions drawn from it. There are concerns that the study over-estimated the risk of breast cancer associated with a short exposure to menopausal hormone therapy.

AB - In the Million Women Study, published in August 2003 participated nearly one million posstmenopausal women. The authors found unusually high breast cancer risk among the estrogen-progesterone hormone treated patients, and small, but significant increases in other hormone treated groups, including tibolone. Following publication of the Million Women Study, the Committee of Safety of Medicines wrote to all doctors in UK, advising them of breast cancer risk associated with HRT. As a results of the warnings, many women have been wrongly advised to stop, or not even start HRT, with subsequent deterioration in their general health and weell-being. It coused concern among health professionals and women about the use of menopausal hormon treatment. We give an extensive response to the article and its critics, highlighting flaws in the design of the study, which now render unsound any firm conclusions drawn from it. There are concerns that the study over-estimated the risk of breast cancer associated with a short exposure to menopausal hormone therapy.

KW - Beast cancer risk

KW - Estrogen-progesterone therapy

KW - Menopausa

UR - http://www.scopus.com/inward/record.url?scp=2542502355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542502355&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:2542502355

VL - 67

SP - 123

EP - 130

JO - Magyar Noorvosok Lapja

JF - Magyar Noorvosok Lapja

SN - 0025-021X

IS - 3

ER -